MRD / Regn No. : 20260000585 Date : 30/06/2026
Patient Name : Rupesh Chopra Age & Gender : 39 Yrs. / Male
Contact No. : 9878401819 UHID :
Ht / Wt / BMI : 171 / / 0.00 BP S / BP D : /
Allergies : NKA Referred By :
   
Problem List : OBESITY (30/Jun/2021) | OBSTRUCTIVE SLEEP APNEA (30/Jun/2022) |
Subjective : DR KAMALESWARI,FEELS BLOATED,SLEEP APNEA
Objective : NONE
Analysis : OBESITY,SLEEP APNEA
Plan : START TIRZEPATIDE 2.5 MG,LIFESTYLE CHANGES  
Salient Investigations : FUNDUS GLAUCOMA: NDR | FUNDUS MACULAR DEGENERATION: NAD | FUNDUS PHOTOGRAPH: NAD | OCULAR PRESSURE LEFT: 0,4 mmHg | OCULAR PRESSURE R: 0.6 mm HG | FUNDUS GLAUCOMA: NDR | FUNDUS MACULAR DEGENERATION: NAD | FUNDUS PHOTOGRAPH: NAD | OCULAR PRESSURE LEFT: 0,4 mmHg | OCULAR PRESSURE R: 0.6 mm HG
S# Generic (Trade) Name Route Dosage Usage Duration
1 INJECTION TIRZEPATIDE 2.5 MG
MOUNJARO
Medicine For DIABETES OBESITY
SQ ONCE A WEEK AS DIRECTED
TILL NEXT VISIT
MAY CAUSE NAUSEA AND VISUAL DISTURBANCES
       
Refill : 0 / Substitution:    
Education :
Next Visit : 30/Jul/2026
Tests Suggested For Next Visit :
   
   

Dr. Krishna G Seshadri
Sr. Consultant Endocrinology Diabetes and Metabolism
Tamil Nadu / 48748 HPRID: 71-0638-2075-7542

This is a Computer generated Prescription

Powered By: